Ali Behbahani, Director at Nevro Corp, holds 4.49M shares in Black Diamond Therapeutics (Ticker: BDTX), holds 24.47M shares in Savara (Ticker: SVRA), holds 2.19M shares in Mirum Pharmaceuticals (Ticker: MIRM).
Ali Behbahani latest transaction was an Uninformative Buy of $11.88K.
What was Ali Behbahani's most profitable transaction?
Ali Behbahani’s most profitable transaction was an Informative Buy of MIRM stock on July 24, 2019. The return on the trade was 47.80%.
What is Ali Behbahani's role in Nevro Corp?
Ali Behbahani's role in Nevro Corp is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.